DJ Blueprint Medicines Is Maintained at Equal-Weight by Barclays
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
February 18, 2021 09:57 ET (14:57 GMT)
DJ Blueprint Medicines Price Target Raised to $95.00/Share From $90.00 by Barclays
Ratings actions from Benzinga: https://www.benzinga.com/stock/BPMC/ratings
(END) Dow Jones Newswires
February 18, 2021 09:57 ET (14:57 GMT)